Somerset Group’s Edwards Lifesciences EW Stock Holding History

Somerset Group’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-122,286	Closed	-$1.37M	–	83
2013 Q2	$1.37M	Buy	+122,286	New	+$1.45M	1.02%	34

Other funds holding EW

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Somerset Group's EW Position: Q3 2013 in Review

Somerset Group sold out of Edwards Lifesciences (EW) in Q3 2013, closing a stake of 122,286 shares — an estimated $1.37M sold.

Somerset Group first reported a position in EW in Q2 2013 and held it in 1 quarter. The position peaked at $1.37M in Q2 2013. 409 funds tracked by Wall St. Rank hold EW as of Q3 2013.

Somerset Group reported no remaining Edwards Lifesciences position as of Q3 2013 after selling out during the quarter.
Somerset Group sold 122,286 Edwards Lifesciences shares in Q3 2013, an estimated $1.37M.
Somerset Group first reported a position in Edwards Lifesciences in Q2 2013 and held it in 1 quarter.
Somerset Group's Edwards Lifesciences position peaked at $1.37M in Q2 2013.
409 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2013.

Based on Somerset Group's 13F filing for Q3 2013, filed 14 Nov 2013.